Don't miss
- Kidnapped Victim SpeaksPosted 12 hours ago
- UPDATE: More Arrests Made Related to Car BurglariesPosted 12 hours ago
- Deceased Army Ammunition Plant Workers RememberedPosted 13 hours ago
- Henderson, McDonough Qualify for Federal Disaster Aid; Warren County Does NotPosted 17 hours ago
- Grocery Store on the Hill to ClosePosted 17 hours ago
- One-Time Drug Court Administrator Accused of Making DrugsPosted 17 hours ago
Breast Cancer Drug Approved By FDA
By Brian Crozier on February 23, 2013
THE FOOD AND DRUG ADMINISTRATION HAS APPROVED A FIRST-OF-A-KIND BREAST CANCER MEDICATION THAT TARGETS TUMOR CELLS WHILE SPARING HEALTHY ONES.
THE DRUG KADCYLA FROM ROCHE COMBINES THE ESTABLISHED DRUG HERCEPTIN WITH A POWERFUL CHEMOTHERAPY DRUG AND A THIRD CHEMICAL LINKING THE MEDICINES TOGETHER. THE CHEMICAL KEEPS THE COCKTAIL INTACT UNTIL IT BINDS TO A CANCER CELL, DELIVERING A POTENT DOSE OF ANTI-TUMOR POISON. CANCER RESEARCHERS SAY THE DRUG IS AN IMPORTANT STEP FORWARD IN THE FIGHT AGAINST BREAST CANCER.








